Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease
Clinical trial NCT04769648 · UNKNOWN
Trial details
- NCT number
- NCT04769648
- Sponsor
- Glia, LLC
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-15
- Primary completion
- 2023-08-15
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.